References
<A NAME="RZ10004SS-1">1</A>
New address: Jean-Pierre Férézou, IPD-Farma, Avenida Churchill, 129; sl. 1003, CEP
20020-050 - Centro - Rio de Janeiro, RJ, Brazil. E-mail: ferezou@terra.com.br.
<A NAME="RZ10004SS-2A">2a</A>
Werner G.
Hagenmaier H.
Albert K.
Kohlshorn H.
Drautz H.
Tetrahedron Lett.
1983,
24:
5193
<A NAME="RZ10004SS-2B">2b</A>
Werner G.
Hagenmaier H.
Drautz H.
Baumgartner A.
Zähner H.
J. Antibiot.
1984,
37:
110
<A NAME="RZ10004SS-2C">2c</A> For structure elucidation, see:
Corey EJ.
Ponder JW.
Tetrahedron Lett.
1984,
25:
4325
<A NAME="RZ10004SS-2D">2d</A>
Baker GH.
Brown PJ.
Dorgan RJJ.
Everett JR.
Ley SV.
Slawin AMZ.
Williams DJ.
Tetrahedron Lett.
1987,
28:
5565
<A NAME="RZ10004SS-3">3</A>
Bindseil KU.
Zeeck A.
Liebigs Ann. Chem.
1994,
305
For a review on V-ATPases, see:
<A NAME="RZ10004SS-4A">4a</A>
Forgac M.
Physiol. Rev.
1989,
69:
765
<A NAME="RZ10004SS-4B">4b</A>
Finbow ME.
Harrison MA.
Biochem. J.
1997,
324:
697
<A NAME="RZ10004SS-4C">4c</A>
Nishi T.
Forgac M.
Nat. Rev. Mol. Cell Bio.
2002,
3:
94
<A NAME="RZ10004SS-5">5</A> Review:
Gagliardi S.
Rees M.
Farina C.
Curr. Med. Chem.
1999,
6:
1197
Total syntheses of Bafilomycin A1:
<A NAME="RZ10004SS-6A">6a</A>
Evans DA.
Calter MA.
Tetrahedron Lett.
1993,
34:
6871
<A NAME="RZ10004SS-6B">6b</A>
Toshima K.
Jyojima T.
Yamaguchi H.
Murase H.
Yoshida T.
Matsumura S.
Nakata M.
Tetrahedron Lett.
1996,
37:
1069
<A NAME="RZ10004SS-6C">6c</A>
Toshima K.
Yamaguchi H.
Jyojima T.
Noguchi Y.
Nakata M.
Matsumura S.
Tetrahedron Lett.
1996,
37:
1073
<A NAME="RZ10004SS-6D">6d</A>
Toshima K.
Jyojima T.
Noguchi Y.
Yoshida T.
Murase M.
Nakata M.
Matsumura S.
J. Org. Chem.
1997,
62:
327
<A NAME="RZ10004SS-6E">6e</A>
Scheidt KA.
Tasaka A.
Bannister TD.
Wendt MD.
Roush WR.
Angew. Chem. Int. Ed.
1999,
38:
1652
<A NAME="RZ10004SS-6F">6f</A>
Scheidt KA.
Bannister TD.
Tasaka A.
Wendt MD.
Savall BM.
Fegley GJ.
Roush WR.
J. Am. Chem. Soc.
2002,
124:
6981
<A NAME="RZ10004SS-6G">6g</A>
Hanessian S.
Ma J.
Wang W.
J. Am. Chem. Soc.
2001,
123:
10200
<A NAME="RZ10004SS-6H">6h</A> Total Synthesis of Bafilomycin V2:
Marshall JA.
Adams ND.
J. Org. Chem.
2002,
67:
733
<A NAME="RZ10004SS-7">7</A>
Poupon J.-C.
Demont E.
Prunet J.
Férézou J.-P.
J. Org. Chem.
2003,
68:
4700
Reviews:
<A NAME="RZ10004SS-8A">8a</A>
Boivin B.
Tetrahedron
1987,
43:
3309
<A NAME="RZ10004SS-8B">8b</A>
Perron F.
Albizati KF.
Chem. Rev.
1989,
89:
1617
<A NAME="RZ10004SS-8C">8c</A>
Vaillancourt V.
Pratt NE.
Perron F.
Albizati KM. In The Total Synthesis of Natural Products
Vol. 8:
ApSimon J.
Wiley Interscience;
New York:
1992.
p.533
Representative examples:
<A NAME="RZ10004SS-9A">9a</A>
Hoye TR.
Peck DR.
Swanson TA.
J. Am. Chem. Soc.
1984,
106:
2738
<A NAME="RZ10004SS-9B">9b</A>
Bernet B.
Bishop PM.
Caron M.
Kawamata T.
Roy BL.
Ruest L.
Sauvé G.
Soucy P.
Deslongchamps P.
Can. J. Chem.
1985,
63:
2818 , and preceding communications in the issue
<A NAME="RZ10004SS-9C">9c</A>
Ireland RE.
Daub JP.
Mandel GS.
Mandel NS.
J. Org. Chem.
1983,
48:
1312
<A NAME="RZ10004SS-9D">9d</A>
Schreiber SL.
Wang Z.
J. Am. Chem. Soc.
1985,
107:
5303
<A NAME="RZ10004SS-9E">9e</A>
Totah NI.
Schreiber SL.
J. Org. Chem.
1991,
56:
6255
<A NAME="RZ10004SS-9F">9f</A>
Zhao Y.
Pratt NE.
Heeg MJ.
Albizati KF.
J. Org. Chem.
1993,
58:
1300
<A NAME="RZ10004SS-9G">9g</A>
Martin SF.
Lee W.-C.
Pacofsky GJ.
Gist RP.
Mulhern TA.
J. Am. Chem. Soc.
1994,
116:
4674
<A NAME="RZ10004SS-9H">9h</A>
Oikawa M.
Ueno T.
Oikawa H.
Ichihara A.
J. Org. Chem.
1995,
60:
5048
<A NAME="RZ10004SS-9I">9i</A>
Ireland RE.
Longbin L.
Roper TD.
Tetrahedron
1997,
53:
13221
<A NAME="RZ10004SS-9J">9j</A>
Ireland RE.
Longbin L.
Roper TD.
Gleason JL.
Tetrahedron
1997,
53:
13257
<A NAME="RZ10004SS-10">10</A>
Poupon J.-C.
Lopez R.
Prunet J.
Férézou J.-P.
J. Org. Chem.
2002,
67:
2118
<A NAME="RZ10004SS-11">11</A>
The present preliminary work has been developed from racemic aldehyde 6.
<A NAME="RZ10004SS-12">12</A>
Roush WR.
Bannister TD.
Tetrahedron Lett.
1992,
33:
3587
<A NAME="RZ10004SS-13">13</A>
Paterson I.
Bower S.
McLeod MD.
Tetrahedron Lett.
1995,
36:
175
<A NAME="RZ10004SS-14">14</A>
Henryon V.
Lopez R.
Prunet J.
Férézou J.-P.
Synthesis
2001,
2401
<A NAME="RZ10004SS-15">15</A>
Submitted for publication.
<A NAME="RZ10004SS-16A">16a</A>
Johnson AW.
Markham E.
Price R.
Org. Synth.
1973,
6:
785
<A NAME="RZ10004SS-16B">16b</A>
Krägeloh K.
Simchen G.
Synthesis
1980,
30
<A NAME="RZ10004SS-17A">17a</A>
See ref. 14: This aldehyde was prepared using the racemic version of the Hoppe homoaldolisation
reaction (Hoppe, D.; Zschage, O. Angew. Chem., Int. Ed. Engl. 1989, 28, 69). The asymmetric version of this reaction using (-)-sparteine instead of TMEDA
(Zschage, O.; Hoppe, D. Tetrahedron 1992, 48, 5657) will easily provide the enantiopure aldehyde required for asymmetric synthesis
of bafilomyin A1.
<A NAME="RZ10004SS-17B">17b</A> For an alternative route to this aldehyde, see:
Baker R.
Swain CJ.
Head JC.
J. Chem. Soc., Chem. Commun.
1985,
309
<A NAME="RZ10004SS-17C">17c</A> See also:
Baker R.
Swain CJ.
Head JC.
J. Chem. Soc., Perkin Trans. 1
1988,
85
<A NAME="RZ10004SS-18A">18a</A>
Evans DA.
Duffy JL.
Dart MJ.
Tetrahedron Lett.
1994,
35:
8537
<A NAME="RZ10004SS-18B">18b</A> These authors have proposed the 1,3-merged model for explaining the observed
diasteroselectivity:
Evans DA.
Dart MJ.
Duffy JL.
Yang M.
J. Am. Chem. Soc.
1996,
118:
4322
<A NAME="RZ10004SS-18C">18c</A> See also:
Evans DA.
Dart MJ.
Duffy JL.
Yang M.
Livingston AB.
J. Am. Chem. Soc.
1995,
117:
6619
<A NAME="RZ10004SS-19">19</A>
Hanessian S.
Tehim A.
Meng Q.
Granberg K.
Tetrahedron Lett.
1996,
37:
9001
<A NAME="RZ10004SS-20A">20a</A>
Gatti PA.
Gagliardi S.
Cerri A.
Farina C.
Tetrahedron Lett.
1997,
38:
6949
<A NAME="RZ10004SS-20B">20b</A>
From a mechanistic point of view a preliminary cyclization of 11 to 17 (that can exist in equilibrium with 18) followed by a base-catalyzed fragmentation of 18 exhibiting a favorable antiperiplanar disposition can be claimed to give enolate
19 or its ketone form 20, which can subsequently undergo a desilylation-cyclization reaction to give 15 or a β-elimination of the 21-acetoxy group to furnish 16 according to Scheme
[12]
:
<A NAME="RZ10004SS-21">21</A> Use of montmorillonite K 10 for ketal formation, see:
Taylor EC.
Chiang CS.
Synthesis
1977,
467 ; Under classical conditions (MeOH/acid), only rearrangement or elimination products
were observed
<A NAME="RZ10004SS-22A">22a</A>
Férézou J.-P.
Gauchet-Prunet J.
Julia M.
Pancrazi A.
Tetrahedron Lett.
1988,
30:
3667
<A NAME="RZ10004SS-22B">22b</A>
Férézou JP.
Julia M.
Li Y.
Liu L.-W.
Pancrazi A.
Bull. Soc. Chim. Fr.
1995,
132:
428
<A NAME="RZ10004SS-23">23</A>
Aldol 6 (
O
TES) was isolated in 70% yield as a 9:1 mixture of two enol forms. The selectivity was
determined by 1H NMR integration of the H-21 signal on the crude material.
<A NAME="RZ10004SS-24A">24a</A>
Dellaria JF.
Santarsiero BD.
J. Org. Chem.
1989,
54:
3916
<A NAME="RZ10004SS-24B">24b</A>
Williams RM.
Im MN.
J. Am. Chem. Soc.
1991,
113:
9276
<A NAME="RZ10004SS-24C">24c</A>
Snyder L.
Meyers AI.
J. Org. Chem.
1993,
58:
7507
<A NAME="RZ10004SS-25">25</A>
Barrett AGM.
Carr RAE.
Finch MAW.
Florent J.-C.
Richardson G.
Walshe NDA.
J. Org. Chem.
1986,
51:
4254
<A NAME="RZ10004SS-26">26</A>
Gemal AL.
Luche J.-L.
J. Am. Chem. Soc.
1981,
103:
5454
<A NAME="RZ10004SS-27">27</A>
Crimmins MT.
O’Mahony R.
J. Org. Chem.
1989,
54:
1157
NaBH4 reduction of α-hydroxyesters has already been observed see for example:
<A NAME="RZ10004SS-28A">28a</A>
Epe B.
Oelbermann U.
Mondon A.
Chem. Ber.
1981,
114:
757
<A NAME="RZ10004SS-28B">28b</A>
Payard M.
Mouysset G.
Tronche P.
Bastide P.
Bastide J.
Boas MJ.
Eur. J. Med. Chem. Chim. Ther.
1985,
117
<A NAME="RZ10004SS-29">29</A>
X-ray crystal data for compound 29: Single crystals of 29 were grown by recrystallization from Et2O-MeOH at r.t. Data were collected at 293 (1)K on a Nonius Kappa CCD diffractometer
using an Mo Kα (λ = 071073 Å) X-ray source and a graphite monochromator. Formula:
C30H45NO9Si; M = 59176; triclinic; space group P-1; a = 97330 (2) Å, b = 120870 (3) Å, c =
155750 (4) Å, α = 902070 (16)°, β = 930680 (16)°, γ = 1095220 (15)°, V = 172403 (7)
Å3; Z = 2; ρcalcd = 1140gcm-3; µ = 0115cm-1; F(000) = 636. Crystal dimensions: 0.20 × 0.20 × 0.20 mm. Total reflections collected
10453 and 4577 with I >2σ(I); maximum θ: 2503°. Goodness of fit on F2 1061; R[I>2σ (i)] = 00577, wR2 = 01778 (all data), 380 parameters; maximum/minimum residual density 0671 (0040)/-0305
(0040) eÅ-3. The crystal structure was solved in SIR 97
[30]
and refined in SHELXL-97
[31]
by full matrix least-squares using anisotropic thermal displacement parameters for
all non-hydrogen atoms. Crystallographic data (excluding structure factors) have been
deposited with the Cambridge Crystallographic Data Centre as supplementary publication
no. 239437. Copies of the data can be obtained free of charge on application to the
CCDC 12 Union Road Cambridge CB2 1EZ UK (fax:+44 (1223)336033 or e-mail: deposit@ccdc.cam.ac.uk).
<A NAME="RZ10004SS-30">30</A>
Altomare A.
Burla MC.
Camalli M.
Cascarano G.
Giacovazzo C.
Guagliardi A.
Moliterni AGG.
Polidori G.
Spagna R.
SIR97, An integrated package of computer programs for the solution and refinement
of crystal structures using single crystal data
1999.
<A NAME="RZ10004SS-31">31</A>
Sheldrick GM.
SHELXL-97
Universität Göttingen;
Germany:
1997.
<A NAME="RZ10004SS-32">32</A>
Mitsunobu O.
Synthesis
1981,
11
For more details on the mechanism of the Mitsunobu inversion reaction, see:
<A NAME="RZ10004SS-33A">33a</A>
Varasi M.
Walker KAM.
Maddox ML.
J. Org. Chem.
1987,
52:
4235
<A NAME="RZ10004SS-33B">33b</A>
Hughes DL.
Reamer RA.
Bergan JJ.
Grabowski EJJ.
J. Am. Chem. Soc.
1988,
110:
6487
<A NAME="RZ10004SS-33C">33c</A>
Camp D.
Jenkins ID.
J. Org. Chem.
1989,
54:
3045
<A NAME="RZ10004SS-33D">33d</A>
Hughes DL.
Org. React.
1992,
42:
335
<A NAME="RZ10004SS-34A">34a</A>
Lumin S.
Yadagiri P.
Falck JR.
Tetrahedron Lett.
1988,
29:
4237
<A NAME="RZ10004SS-34B">34b</A>
Ramesh NG.
Balasubramanian KK.
Tetrahedron
1995,
51:
255
<A NAME="RZ10004SS-35">35</A>
For model experiments see ref. 10 and references therein.
<A NAME="RZ10004SS-36A">36a</A>
Pedretti V.
Mallet J.-M.
Sinaӱ P.
Carbohydr. Res.
1993,
247
<A NAME="RZ10004SS-36B">36b</A>
Stork G.
Khan M.
J. Am. Chem. Soc.
1985,
107:
500
<A NAME="RZ10004SS-37">37</A> Compare, for example (one-pot sequences):
Burke SD.
Deaton DN.
Olsen RJ.
Armistead DM.
Blough BE.
Tetrahedron Lett.
1987,
28:
3905
<A NAME="RZ10004SS-38">38</A>
X-ray analysis of a monocrystal from the major isomer confirmed that except for C-15,
all the stereogenic centers possess the relative stereochemistry required for Bafilomycin
A1, but the disorder resulting from the TBS groups renders the structure unpublishable
(R = 15%).
<A NAME="RZ10004SS-39">39</A>
Tabusa F.
Yamada T.
Suzuki K.
Mukaiyama T.
Chem. Lett.
1984,
405
<A NAME="RZ10004SS-40A">40a</A>
Zhang HX.
Guibé F.
Balavoine G.
J. Org. Chem.
1990,
55:
1857
<A NAME="RZ10004SS-40B">40b</A>
Trost B.
Li C.-J.
Synthesis
1994,
1267
<A NAME="RZ10004SS-40C">40c</A> A first attempt of Pd-catalyzed hydrostannylation on small scale gave 2b (PG = TBS) along with its regioisomer (80%, 3:1 mixture). For comparison with alternative
methodologies, see also:
Betzer J.-F.
Delaloge F.
Muller B.
Pancrazi A.
Prunet J.
J. Org. Chem.
1997,
62:
7768
<A NAME="RZ10004SS-41">41</A>
Evans DA.
Ratz AM.
Huff BE.
Sheppard GS.
J. Am. Chem. Soc.
1995,
117:
3448